A federal medical advisory panel recommended last month that the diabetes drug, Avandia, should either be withdrawn from the market or have sales severely restricted because it increases the... Read more
Device maker Medtronic got some bad news recently when a study showed that its new drug-coated stent was associated with more heart attacks and blood clots than a rival stent made by Johnson... Read more
Since a meta-analysis was made public in May 2007, Avandia, GlaxoSmithKline’s diabetes drug, has come under fire. The meta-analysis showed the medicine was increasing the risk of heart... Read more
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.